Representing a powerful example of collaboration between industry and academia is SPARK – a program helping accelerate the drug development process.

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Could aquatic bacteria hold the keys to bolstering our drug pipelines?

Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?

A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.

Answer: Anything that will fit! A competition challenges artists to create a masterpiece that fits inside a pharmaceutical capsule.

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients.

Sitting Down With… Jinling Chen, Vice President, Pharmaceutical Development Services, WuXi STA, China.

Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.